FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM
A phase 3 trial of Irinotecan, Floxuridine, Leucovorin, Fluorouracil and Oxaliplatin in Colorectal cancer, run by Sun Yat-sen University, recorded as terminated on the registry.
Overview
FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM is a phase 3 interventional study registered as NCT03678428 by Sun Yat-sen University, with 92 participants recorded, started 2021-12-31 and due to reach its primary completion in 2022-10-31. Interventions recorded: Irinotecan, Oxaliplatin HAI, Floxuridine, Leucovorin, 5-FU, Oxaliplatin. Conditions recorded: Metastatic Colorectal Cancer, Liver Metastases.
Linked to the drug Floxuridine because the registry names it among its interventions and Colorectal cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialTesting Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Shares Floxuridine, Leucovorin (folinic acid), Irinotecan (and liposomal irinotecan), Oxaliplatin and the tag pipeline.
- TrialCombination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Shares Leucovorin (folinic acid), Irinotecan (and liposomal irinotecan), Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
- TrialOxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer
Shares Floxuridine, Oxaliplatin, Colorectal cancer and the tag pipeline.
- TrialG-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer
Shares Leucovorin (folinic acid), Irinotecan (and liposomal irinotecan), Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
- TrialCediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer
Shares Leucovorin (folinic acid), Oxaliplatin, Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
- TrialPalliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Shares Leucovorin (folinic acid), Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
- TrialA Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan
Shares Irinotecan (and liposomal irinotecan), Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
- TrialEvaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer
Shares Leucovorin (folinic acid), Oxaliplatin and the tag pipeline.